BROOKE GREEN: Open Payments
NPI 1154001253 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 61 payments from 14 companies in 2025. Trend: 2023 $225 · 2024 $926 · 2025 $1,504
Food & beverage: $1,504
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 19 | $311 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $271 |
| Alkermes, Inc. | 3 | $165 |
| Teva Pharmaceuticals USA, Inc. | 3 | $149 |
| Supernus Pharmaceuticals, Inc. | 6 | $148 |
| Lundbeck LLC | 5 | $97 |
| CeQur Corporation | 1 | $87 |
| ABBVIE INC. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
Products named: Auvelity, CAPLYTA, UZEDY, Qelbree, LYBALVI, REXULTI, CeQur Simplicity, VRAYLAR.
Industry payments across VA — which companies pay providers there.
